TOP STORIES

• BUSINESS Qol’s Mr Takada Hints at Continued Use of Long-Listed Drugs from Makers Hiring Apo Plus MRs
  October 17, 2012

• BUSINESS MTPC’s Oral MS Treatment Charging towards Blockbuster Territory
  October 16, 2012

• BUSINESS Towa Pharmaceutical Expanding Direct-Sales Network as Its Distributors Face Lack of Successors
  October 15, 2012

• ACADEMIA We Would Like to Provide iPS Cells with Medical History Identification: Prof. Yamanaka of Kyoto University
  October 15, 2012

• BUSINESS Radical AD Treatments Hit “PIII Wall” Again, but Amyloid β Hypothesis Remains Unshaken
  October 15, 2012

• REGULATORY MHLW to Begin Pilot Study on Drug Risk Management Plans for Generics
  October 12, 2012

• ORGANIZATION Price Gap between Long-Listed Products, Generics Necessary: FPMAJ Chairman Naito
  October 11, 2012

• BUSINESS Lack of Patient Satisfaction with BPH Treatments Offers Opportunity; Can Kissei Get Them to Switch to Urief?
  October 11, 2012

• BUSINESS Biz Entertainment Spending by MRs Falls at Most Companies, Down 80% at Foreign Firm: Jiho Poll 
  October 10, 2012

• ORGANIZATION Life Science Budget in Japan Lacks Absolute Amount: JPMA President Teshirogi
  October 10, 2012

• REGULATORY Dr Takenaka Tapped as NIBIO Advisor, Committed to Creation of Drug Discovery Network
  October 9, 2012

• BUSINESS GSK’s Requip CR Tablets More Economical and Effective; Sales May Decrease despite Investment in Improved Formulation
  October 8, 2012

• BUSINESS Novartis to See Tasigna Sales More than Double, Value of Glivec Maximized
  October 5, 2012

• REGULATORY Senior Vice Minister Sakurai Calls for Industry-Growth Perspective on Long-Listed Drug Pricing 
  October 4, 2012

• REGULATORY MHLW to Enhance Drug Review System to Eliminate Application Lag: PFSB Director Gen. Ebata
  October 3, 2012

• REGULATORY Pharmacist Mitsui Becomes Health Minister, Industry Hails Appointment
  October 2, 2012

• BUSINESS Daiichi Sankyo, AZ to Step Up Promotion for Nexium upon Lifting of Long-Term Prescription Ban
  October 1, 2012

• REGULATORY Price Gap between Long-Listed Products, Generics Should Be Retained: Mr Chikazawa of MHLW
  September 28, 2012

• BUSINESS Takeda Aims to Become No. 1 in Domestic Diabetes, Cardiovascular Markets: Senior Vice Pres. Iwasaki
  September 27, 2012

• BUSINESS Japan Vaccine Pres. Nagano Eyes One-Third Market Share or More in FY2020
  September 26, 2012

ページ

• « 先頭
• ‹ Prev
• …
• 207
• 208
• 209
• 210
• 211
• 212
• 213
• 214
• 215
• …
• Next ›
• 最終 »